The following is a summary of “Recent advances and applications of optical coherence tomography angiography in diabetic ...

Credit: SUPERMAO/Shutterstock. Vantage Biosciences has dosed the first subject in the randomised Phase II trial of oral therapy VX-01 to treat non-proliferative diabetic retinopathy (NPDR). The ...

As the burden of diabetes continues to rise in India, diabetic retinopathy has emerged as one of its most debilitating complications—often leading to irreversible vision loss if left undiagnosed.

Background: Diabetic retinopathy, a major microvascular complication ... and medical examinations such as fluorescein fundus angiography (FFA) are required for detection. Only in the middle and late ...

It is currently scaling an AI solution that it began piloting in 2022: Digital Diagnostics’ AI system that autonomously diagnoses diabetic retinopathy. The system, called the LumineticsCore ...

Fasting C-peptide (FCP) shows a nonlinear relationship with diabetic retinopathy (DR) risk, with a protective effect below 4.11 ng/mL. Above 4.11 ng/mL, the protective effect of FCP on DR becomes ...

Researchers from the Czech Republic, led by first author Martin Sín, MD, PhD, FEBO, reported that an AI system from Aireen exhibited greater sensitivity and specificity for screening diabetic ...

Researchers have observed in a new study that stress hyperglycemia (SHR) ratio could be a useful predictor of neovascular glaucoma (NVG) in patients with ...

Introduction Diabetic retinopathy is one of the leading causes of vision impairment globally. Alongside the systemic control of diabetes and timely detection of diabetic retinopathy, the prompt ...

Fluorescein angiography involves an IV injection of fluorescein, an organic molecule that fluoresces when exposed to short-wavelength light (465-490 nm). This imaging technique can characterize ...

Department of Endocrinology, The Third Affiliated Hospital of Anhui Medical University (The First People’s Hospital of Hefei), Hefei, China Background: Diabetic retinopathy (DR) is a major contributor ...